Fact sheet on the different coverage and cost-sharing considerations for LAI ART across public and private payers – including Medicaid, Medicare, and commercial insurance – and provides information to RWHAP recipients and subrecipients so they can help clients navigate access to LAI ART through these different payers.
LAI ART is a form of HIV treatment that is available as an injection, received routinely by an individual (monthly or bi-monthly), and administered by a clinician or other health care professional. LAI ART may be an option for people with HIV who experience barriers related to adherence to once-daily pill regimens, and prefer monthly or bi-monthly injections.
For more information about this fact sheet’s purpose and why it will be helpful to RWHAP recipients and their clients, visit this TargetHIV blog post.